Evidence map›Paper›PMID 39890718›Full record

ArticleArchives of dermatological research2025

Typha pollen extract inhibit melanogenesis via α-MSH/MC1R signaling pathway in B16 and melasma mouse model.

Shiqian Zheng, Rongrong Deng, Shengjun Xie, Gengjiu Huang, Zhiwen Ou, Zhibin Shen

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shiqian ZhengGuangdong Botanical Beauty Care Biotechnology Co., Ltd, Guangzhou, China.
Rongrong DengGuangdong Botanical Beauty Care Biotechnology Co., Ltd, Guangzhou, China.
Shengjun XieSchool of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Gengjiu HuangGuangdong Botanical Beauty Care Biotechnology Co., Ltd, Guangzhou, China.
Zhiwen OuGuangdong Botanical Beauty Care Biotechnology Co., Ltd, Guangzhou, China.
Zhibin ShenGuangdong Botanical Beauty Care Biotechnology Co., Ltd, Guangzhou, China. szb8113@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the effects of Typha Pollen extract on melanogenesis in B16 and melasma mouse model. The effects of TP extract on B16 viability, melanin content of B16, MC1R content and TYR activity were studied by MTT assay, NaOH method, ELISA assay and dopa oxidation assay, respectively. In melasma mouse model, the effects of TP extract on MC1R content, MITF content and TYR activity were studied by ELISA assay, immunofluorescence staining and dopa oxidation assay, respectively. The results showed that the appropriate concentration of TP extract does not affect cell viability, and that TP extract inhibit B16 melanin, MC1R content and TYR activity. The results showed that TP extract inhibit skin MC1R content, MITF content and TYR activity. TP extract inhibit B16 melanin, inhibit proteins of α-MSH/MC1R signaling pathway such as MC1R, MITF and TYR. So TP extract is a natural and effective potential whitening agent.

Indexed as

alpha-MSHMelaninsMelanoma, ExperimentalMelanosisPlant ExtractsReceptor, Melanocortin, Type 1AnimalsCell SurvivalDisease Models, AnimalMelanogenesisMiceMicrophthalmia-Associated Transcription FactorMonophenol MonooxygenasePollenSignal Transductionalpha-MSHMelaninsMicrophthalmia-Associated Transcription FactorMitf protein, mouseMonophenol MonooxygenasePlant ExtractsReceptor, Melanocortin, Type 1MelanogenesisPuhuangTypha pollen extractα-MSH/MC1R signaling pathway

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.